VOR — Vor Biopharma Inc. price, chart and key statistics

Price data

Price

$19.03

YTD price return

+45.49%

YTD total return

+45.49%

Next earnings

Nov 12, 2026

Market cap

1.1B2025-09 507.2M2026-10 1.1B+122.0% over the window

Enterprise value

662.6M

Shares outstanding

59.2M2025-09 10.4M2026-06 59.2M+468.3% over the window

52W low

$6.50

52W high

$30.40

From 52W high

-37.40%

From 52W low

+192.77%

52W range

52%

Volume

Rel volume

0.67×

30D volume

1.2M

30D $ vol

23.9M

Fundamentals

EPS (ttm)

$11.562021-12 -$2.102026-06 $11.56-650.5% over the window

FCF (ttm)

-140.8M2020-12 -40.5M2026-06 -140.8M+248.1% over the window

FCF/share

-$2.382025-03 -$9.662026-06 -$2.38-75.4% over the window

Book value/share

-$3.382025-03 $6.352026-06 -$3.38-153.3% over the window

ROA

130.50%2020-12 -57.1%2026-06 130.5%-328.6% over the window

Current ratio

19.152020-12 4.812026-06 19.15+298.0% over the window

Per-share growth (CAGR, ttm) · 10Y

Price

-35.36%2025-10-20 → 2026-10-20$29.43 → $19.03 (-35.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-25.05%2023-10-20 → 2026-10-20$45.20 → $19.03 (-57.9% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-43.03%2021-10-20 → 2026-10-20$317.00 → $19.03 (-94.0% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.n/a

Total return

-35.36%2025-10-20 → 2026-10-20$29.43 → $19.03 (-35.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-25.05%2023-10-20 → 2026-10-20$45.20 → $19.03 (-57.9% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-43.03%2021-10-20 → 2026-10-20$317.00 → $19.03 (-94.0% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.n/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.

1.6×2021-12 -110.672026-10 1.79-101.6% over the window

Fwd P/E

-4.8×

P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.

-5.6×2025-09 -0.232026-10 -5.62+2367.6% over the window

FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.

-12.51%2025-06 -22.5%2026-06 -12.9%-42.5% over the window

Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($-70.1M) ÷ today's market cap ($1.1B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.

-6.23%2025-06 -0.0%2026-06 -6.4%+36581.8% over the window

Shareholder yield (cash, ttm)(TTM buybacks net of issuance $-70.1M + TTM dividends $0) ÷ today's market cap ($1.1B). Same caveat as the cash buyback yield.

-6.23%2025-06 -0.0%2026-06 -6.4%+36581.8% over the window